The effects of vitamin and mineral supplementation on symptoms of schizophrenia: a systematic review and meta-analysis

A nutrition intervention is effective in improving dietary components linked to cardiometabolic risk in youth with first-episode psychosis

(2016) Scott B. Teasdale et al.   BRITISH JOURNAL OF NUTRITION

A randomized controlled study of the efficacy of six-month supplementation with concentrated fish oil rich in omega-3 polyunsaturated fatty acids in first episode schizophrenia

(2016) Tomasz Pawełczyk et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Emerging Treatments in Schizophrenia

(2016) Hannah E. Brown et al.   HARVARD REVIEW OF PSYCHIATRY

Serum vitamin D and hippocampal gray matter volume in schizophrenia

(2015) Venkataram Shivakumar et al.   PSYCHIATRY RESEARCH-NEUROIMAGING

Diet, exercise and the metabolic syndrome in schizophrenia: A cross-sectional study

(2015) Adrian Heald et al.   SCHIZOPHRENIA RESEARCH

Vitamin–mineral treatment of attention-deficit hyperactivity disorder in adults: double-blind randomised placebo-controlled trial

(2014) Julia J. Rucklidge et al.   BRITISH JOURNAL OF PSYCHIATRY

Cognitive–behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias

(2014) S. Jauhar et al.   BRITISH JOURNAL OF PSYCHIATRY

Relationship of low vitamin D status with positive, negative and cognitive symptom domains in people with first-episode schizophrenia

(2014) K.A. Graham et al.   Early Intervention in Psychiatry

Serum Vitamin D Levels in Relation to Schizophrenia: A Systematic Review and Meta-Analysis of Observational Studies

(2014) Ghazaleh Valipour et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Elevated homocysteine level in first-episode schizophrenia patients—the relevance of family history of schizophrenia and lifetime diagnosis of cannabis abuse

(2014) Blazej Misiak et al.   METABOLIC BRAIN DISEASE

Nutritional interventions for the adjunctive treatment of schizophrenia: a brief review

(2014) Megan Anne Arroll et al.   Nutrition Journal

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2013) David Moher   ANNALS OF INTERNAL MEDICINE

Randomized Multicenter Investigation of Folate Plus Vitamin B12Supplementation in Schizophrenia

(2013) Joshua L. Roffman et al.   JAMA Psychiatry

Shaken but unstirred? Effects of micronutrients on stress and trauma after an earthquake: RCT evidence comparing formulas and doses

(2012) Julia J Rucklidge et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Eicosapentaenoic Acid Interventions in Schizophrenia

(2012) Paolo Fusar-Poli et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

The dietary pattern of patients with schizophrenia: A systematic review

(2012) Salvatore Dipasquale et al.   JOURNAL OF PSYCHIATRIC RESEARCH

A meta-analysis of the polyunsaturated fatty acid composition of erythrocyte membranes in schizophrenia

(2012) W.J.M. van der Kemp et al.   SCHIZOPHRENIA RESEARCH

Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects

(2011) Brian J. Miller et al.   BIOLOGICAL PSYCHIATRY

Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention

(2011) Michael Berk et al.   BIPOLAR DISORDERS

Stress and Inflammation Reduce Brain-Derived Neurotrophic Factor Expression in First-Episode Psychosis

(2011) Valeria Mondelli et al.   JOURNAL OF CLINICAL PSYCHIATRY

Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology

(2011) Thomas RE Barnes et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Inflammatory processes in schizophrenia: A promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond

(2011) Urs Meyer et al.   PHARMACOLOGY & THERAPEUTICS

Road to full recovery: longitudinal relationship between symptomatic remission and psychosocial recovery in first-episode psychosis over 7.5 years

(2011) M. Álvarez-Jiménez et al.   PSYCHOLOGICAL MEDICINE

Genetic Variation Throughout the Folate Metabolic Pathway Influences Negative Symptom Severity in Schizophrenia

(2011) J. L. Roffman et al.   SCHIZOPHRENIA BULLETIN

Folate supplementation in schizophrenia: A possible role for MTHFR genotype

(2011) Michele Hill et al.   SCHIZOPHRENIA RESEARCH

Is it time to trial vitamin D supplements for the prevention of schizophrenia?

(2010) John McGrath   ACTA PSYCHIATRICA SCANDINAVICA

Neonatal Vitamin D Status and Risk of Schizophrenia

(2010) John J. McGrath et al.   ARCHIVES OF GENERAL PSYCHIATRY

Reduced folic acid, vitamin B12 and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: Implications for altered one-carbon metabolism

(2009) Anvita Kale et al.   PSYCHIATRY RESEARCH

Preventing the Second Episode: A Systematic Review and Meta-analysis of Psychosocial and Pharmacological Trials in First-Episode psychosis

(2009) Mario Álvarez-Jiménez et al.   SCHIZOPHRENIA BULLETIN

N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial

(2008) Michael Berk et al.   BIOLOGICAL PSYCHIATRY